Skip to content

Anti-aging drug to get human trials

January 29, 2014

David Sinclair, an Australian geneticist now at Harvard Medical School, is planning human trials of nicotinamide adenine dinucleotide (NAD+). This stems from research by Ana Gomes, who discovered that NAD+ reversed aging in SIRT1-deleted mice. (Cell cite here.)

Advertisements
No comments yet

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: